A detailed history of Comerica Bank transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Comerica Bank holds 772 shares of KURA stock, worth $5,627. This represents 0.0% of its overall portfolio holdings.

Number of Shares
772
Previous 221 249.32%
Holding current value
$5,627
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$8.51 - $19.21 $4,689 - $10,584
551 Added 249.32%
772 $6,000
Q1 2024

May 15, 2024

BUY
$13.42 - $23.53 $1,113 - $1,952
83 Added 60.14%
221 $4,000
Q3 2023

Nov 21, 2023

BUY
$8.44 - $11.86 $1,164 - $1,636
138 New
138 $1,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $488M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.